GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines ...

Among seven new medicines recommended for approval by the EMA's human medicine advisory committee at its latest meeting is ...

UK's health regulator on Monday approved GSK's twice-yearly drug for use as an add-on treatment for asthma in patients aged ...

The European Medicines Agency has recommended the approval of GSK's add-on drug to treat asthma and a chronic inflammatory sinus condition, the company said on Friday.

Drugmaker GSK said on Tuesday that Exdensur (depemokimab), an ultra-long-acting biologic to treat respiratory diseases, has ...

ReBoost Nasal Spray was recalled after it was "found to contain yeast/mold and microbial contamination," the FDA states, adding, "There is a reasonable probability that adverse health consequences, ...

She considers herself lucky. She happened to find a doctor who immediately did a biopsy and sent her sample to a lab that likely didn’t have much else to investigate during the pandemic. Whoever her ...

Cystic fibrosis, a genetic disorder, affects lungs and other organs. It causes thick mucus buildup. Researchers have ...

The FDA warns the over-the-counter spray could result in "adverse health consequences," including the risk of life-threatening infections.